These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26398376)

  • 1. The effect of oral contraception on macroprolactin levels in women with macroprolactinemia: A pilot study.
    Krysiak R; Kowalska B; Szkróbka W; Okopień B
    Pharmacol Rep; 2015 Oct; 67(5):854-7. PubMed ID: 26398376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between macroprolactin levels and vitamin D status in premenopausal women with macroprolactinemia: a pilot study.
    Krysiak R; Kowalska B; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):446-50. PubMed ID: 26179930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neutral effect of testosterone therapy on macroprolactin content in men with macroprolactinemia and late-onset hypogonadism.
    Krysiak R; Kowalska B; Szkróbka W; Okopień B
    Pharmacol Rep; 2016 Feb; 68(1):139-43. PubMed ID: 26721365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):22-28. PubMed ID: 31234219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study.
    Krysiak R; Drosdzol-Cop A; Skrzypulec-Plinta V; Okopien B
    Endocrine; 2016 Jul; 53(1):291-8. PubMed ID: 26902871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM; Smith TP; Gibney J; McKenna TJ
    Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and reproductive manifestations of macroprolactinemia.
    Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
    Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Neutral Effect of Metformin Treatment on Macroprolactin Content in Women with Macroprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):223-228. PubMed ID: 27750350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN; Liew D; Ratnam SS
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):7-13. PubMed ID: 31185509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prolactin and macroprolactin levels in diabetic nephropathy.
    Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R
    Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral contraceptives on serum prolactin: a longitudinal study in 126 normal premenopausal women.
    Hwang PL; Ng CS; Cheong ST
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):127-33. PubMed ID: 3708872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
    Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
    Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
    Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.